![Søren Møller](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Søren Møller
Director of Investments chez
Novo Seeds
Profil
Søren Møller is currently Director at Dansk Biotek, Reapplix A, Galecto Biotech ApS, Forendo Pharma Oy, Advanced MR Analytics AB, Biosyntia ApS, NorthSea Therapeutics BV, and Ejendomsselskabet Hvidovre Torv AS.
Managing Partner at Novo Seeds since 2011.
Managing Partner at Novo Planetary Health.
Managing Partner at Novo Holdings A since 2011.
Former Vice Chairman at Danske Spil A. Former Chairman at Affinicon ApS.
Former Director at Livingston International, Inc., Denator AB, EpiTherapeutics ApS, and RSPR Pharma AB. Independent Director at Damora Therapeutics, Inc. from 2020 to 2024.
Global Manager-Bioinformatics & Genomics at Novozymes A from 2010 to 2015.
Head-Lead Identification at Noapab Holdings A. Chief Scientific Officer at Exiqon A from 2010 to 2015.
Education includes a doctorate (1997) and graduate degree (1993) from the Technical University of Denmark.
Postes actifs de Søren Møller
| Sociétés | Poste | Début |
|---|---|---|
Novo Seeds
 Novo Seeds Investment ManagersFinance Novo Seeds invests in companies located in Europe and the United States. The fund targets companies operating in the fields of life science and healthcare technology sectors. It provides financing for seed and early stage capital requirement. | Director of Investments | 01/10/2011 |
Reapplix A/S
 Reapplix A/S Medical SpecialtiesHealth Technology Manufactures wound healing patches made from patient's blood that for the biological treatment and management of diabetic foot ulcers | Directeur/Membre du Conseil | - |
Biosyntia ApS
 Biosyntia ApS BiotechnologyHealth Technology Provides services in synthetic biology and metabolic engineering fields | Directeur/Membre du Conseil | - |
Dansk Biotek
 Dansk Biotek Miscellaneous Commercial ServicesCommercial Services Operates as an industry association for biotech companies with promoting the biotechnological research | Directeur/Membre du Conseil | - |
Galecto Biotech ApS
 Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Manufactures galectin modulators for the treatment of severe diseases which includes fibrosis and cancer | Directeur/Membre du Conseil | - |
NorthSea Therapeutics BV
 NorthSea Therapeutics BV BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel strategies for the treatment of metabolic, inflammatory and fibrotic diseases | Directeur/Membre du Conseil | - |
Forendo Pharma Oy
 Forendo Pharma Oy Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage drug company that develops novel treatments in women’s health | Directeur/Membre du Conseil | - |
Advanced MR Analytics AB
 Advanced MR Analytics AB Medical/Nursing ServicesHealth Services Provides AI-enhanced MRI-based body composition analytics delivering services | Directeur/Membre du Conseil | - |
Novo Holdings A/S (Denmark)
 Novo Holdings A/S (Denmark) Investment ManagersFinance Functions as an alternative investment manager | Corporate Officer/Principal | 01/01/2011 |
| ░░░░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Anciens postes connus de Søren Møller
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░░ ░░░ | ░░░░░░░░░░ | - |
Formation de Søren Møller
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
77
Relations au 1er degré
21
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 21 |
|---|---|
Novozymes A/S
 Novozymes A/S Chemicals: SpecialtyProcess Industries Manufactures and sells specialty chemicals | Process Industries |
Novo Holdings A/S (Denmark)
Novo Holdings A/S (Denmark) Investment ManagersFinance Functions as an alternative investment manager | Finance |
Livingston International, Inc.
 Livingston International, Inc. Air Freight/CouriersTransportation Provides customs brokerage, transportation and integrated logistics services | Transportation |
Noapab Holdings A/S
 Noapab Holdings A/S Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and diagnostics products | Commercial Services |
Technical University of Denmark
 Technical University of Denmark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Exiqon A/S
 Exiqon A/S Miscellaneous Commercial ServicesCommercial Services Engages in the pharmaceutical industry | Commercial Services |
Denator AB
 Denator AB Medical SpecialtiesHealth Technology Provides instruments and consumables that stabilize biological samples | Health Technology |
EpiTherapeutics ApS
 EpiTherapeutics ApS Pharmaceuticals: MajorHealth Technology Develops cancer drugs based on epigenetics | Health Technology |
Dansk Biotek
Dansk Biotek Miscellaneous Commercial ServicesCommercial Services Operates as an industry association for biotech companies with promoting the biotechnological research | Commercial Services |
Novo Seeds
Novo Seeds Investment ManagersFinance Novo Seeds invests in companies located in Europe and the United States. The fund targets companies operating in the fields of life science and healthcare technology sectors. It provides financing for seed and early stage capital requirement. | Finance |
RSPR Pharma AB
 RSPR Pharma AB Pharmaceuticals: MajorHealth Technology Develops therapeutics for inflammatory vascular diseases | Health Technology |
Danske Spil A/S
 Danske Spil A/S Media ConglomeratesConsumer Services Provides lotteries and gambling services | Consumer Services |
Reapplix A/S
Reapplix A/S Medical SpecialtiesHealth Technology Manufactures wound healing patches made from patient's blood that for the biological treatment and management of diabetic foot ulcers | Health Technology |
Galecto Biotech ApS
Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Manufactures galectin modulators for the treatment of severe diseases which includes fibrosis and cancer | Health Technology |
Forendo Pharma Oy
Forendo Pharma Oy Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage drug company that develops novel treatments in women’s health | Health Technology |
Affinicon ApS
 Affinicon ApS Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
Advanced MR Analytics AB
Advanced MR Analytics AB Medical/Nursing ServicesHealth Services Provides AI-enhanced MRI-based body composition analytics delivering services | Health Services |
Biosyntia ApS
Biosyntia ApS BiotechnologyHealth Technology Provides services in synthetic biology and metabolic engineering fields | Health Technology |
NorthSea Therapeutics BV
NorthSea Therapeutics BV BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel strategies for the treatment of metabolic, inflammatory and fibrotic diseases | Health Technology |
Galecto, Inc.
 Galecto, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of severe diseases | Health Technology |
Ejendomsselskabet Hvidovre Torv AS
 Ejendomsselskabet Hvidovre Torv AS Real Estate DevelopmentFinance Engages in rental of commercial real estate properties | Finance |
